Health
Using CRISPR to find a new drug target for multiple sclerosis, inflammatory bowel disease – FierceBiotech
Vanderbilt researchers used CRISPR gene editing to pinpoint a metabolic enzyme that they believe could be blocked to treat MS…
CRISPR gene editing is a popular tool among scientists searching for new targets in treating inflammatory diseases. A team at Vanderbilt University Medical Center used the technology to study the role of metabolism in the functioning of immune cells, and…
Continue Reading
-
Noosa News24 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
General23 hours agoPort’s lease a ‘mistake’ as major parties flag takeover
-
Business22 hours agoThese ASX 200 shares could rise 50% to 60%
-
General21 hours agoAustralia’s Myanmar community mourns earthquake losses